Our vision is to give everyone diagnosed with cancer,
their best chance to become cancer free.

Dr Shetty is the Chief Medical Officer and manages the US office in Houston, Texas. Dr Shetty was the Director of Clinical Operations at Visualase, and a key member of the executive team which led the Houston-based medical startup to a $110 million Medtronic acquisition. He has also led development of products for epilepsy, spinal tumors, radiation necrosis and prostate cancer, and developed a network of clinics offering MRI guided biopsy and focal therapy for prostate cancer. He has a fellowship from MD Anderson Cancer Center and a Biomedical Engineering degree from Texas A&M. He has co-authored 30+peer-reviewed publications in oncology, radiology, neurology and neurosurgery.

Aidan Cousins is Senior Research Engineer and Ferronova cofounder, and since the company’s inception has been responsible for the technical development and design of FerroTrace’s companion magnetometer probe, FerroMag. Aidan completed a bachelor of Applied Science, Applied Physics (1 st class Honours) in 2011, before undertaking a PhD in Engineering at the University of South Australia. In 2014, his PhD work led to patenting a novel magnetometer technology for lymphatic mapping of magnetic tracers. In 2016, shortly after being awarded his PhD, collaborative research with Victoria University of Wellington focussed on manufacture and detection of novel magnetic tracers resulted in the creation of Ferronova. In 2017 Aidan’s PhD work was further recognised for its impact, being award both of his institutions top PhD awards: the Ian Wark Medal (most outstanding PhD thesis) and the Norton Jackson Material Science and Engineering Medal (commitment to real-world application of research).

Melanie is the R&D Manager at Ferronova and has been with the company since the beginning. Prior to working with Ferronova she completed postdoctoral research with Boutiq and Victoria University of Wellington on a range of nanoparticle technologies including the foundational research for Ferronova on iron oxide nanoparticles. This research involved collaboration with a range of institutions including the University of South Australia and the University of Sydney and led to the creation of Ferronova. Melanie holds a PhD in Chemistry from Victoria University of Wellington in New Zealand and has research experience in the synthesis of phosphine ligands, organometallic molecules and metallic nanoparticles with controlled size, shape, and magnetic properties and the surface modification of these particles to ensure biocompatibility. Experienced in the characterisation of these materials including electron microscopy, X-ray crystallography, magnetic measurements, and nuclear magnetic resonance.

Joe El-Aklouk is a seasoned professional with 18 years of experience in the medtech industry. Currently, Joe serves as the Director of Product Management at Ferronova Pty Ltd, where he oversees the development, clinical program, and launch of the company's medical devices and tracer drug products. Before joining Ferronova, Joe was the Product Manager for the Ultrasound portfolio at Ellex Medical. He also held a leadership position at LBT Innovations, where he led the development of an AI-based clinical microbiology platform. At Signostics Ltd, Joe made significant contributions, playing a key role in creating the world’s most accurate AI-based bladder scanner and the smallest diagnostic ultrasound. Joe has a Master of Philosophy (1st class honours) and a Bachelor of Biomedical Engineering from the University of Auckland, NZ. He is credited as the main inventor in 7 international patents. His unique combination of skills and extensive experience positions him as a leader in the development of medical devices and pharmaceuticals.

With over 13 years of experience in quality management, regulatory compliance, and process improvement, she has built a strong foundation in the field, working across Europe and Australia. Leticia holds a Bachelor's Degree in Chemistry from Spain's Vigo University and Italy's Parma University. Additionally, she possesses a triple Master's degree in Quality Management Systems, Environmental Systems, and Occupational Health and Safety from Barcelona University, complemented by a Diploma in Project Management from the Australian Pacific College. Her expertise lies in developing and implementing quality assurance strategies and regulatory frameworks, aligning them with medical device and drug standards, regulations, and stakeholder expectations across the diverse regulations of the US, EU, Australian, and other global markets. Additionally, she has experience in analytical laboratory work and leadership in research and development projects.

BCom (Accounting) University of South Australia, CAANZ As Finance Manager, Belinda oversees the finance function at Ferronova, including financial accounting, management accounting, tax, and company secretarial functions. Previously she worked in public practice with Nexia Edwards Marshall in Adelaide for over a decade working closely with clients to help them meet their taxation and financial reporting obligations. She advised on a range of tax and accounting matters to clients in a wide range of industries including legal, agriculture, health, commercial real estate and retail to name a few, in addition to not-for-profit entities.

Selina Chang is an R&D Chemical Engineer at Ferronova, graduating in 2020 with a Bachelor of Chemical Engineering (Honours) and Bachelor of Science in Chemistry from the University of Adelaide. During her undergraduate studies, she focused on plasma modification for antibacterial biomedical implants and presented her research at Ingenuity 2018. Additionally, Selina actively engaged in social impact projects, working on innovative solutions in Timor-Leste. She participated in an international internship with the fuel assessment team focused on developing a prototype cookstove with reduced smoke emissions. Selina initially joined Ferronova as a student as part of her university placement in 2019 and transitioned to a full-time role after graduating. At Ferronova, Selina focuses on R&D and manufacturing, specifically in the development of nanoparticles for clinical trials. She oversees HSE administration, ensures quality assurance and control, and conducts research to improve synthesis and analytical methods.

Ahmed has more than 15 years of experience in pharmaceutical and medical devices industries. He has a bachelor’s degree of Pharmaceutical Sciences with 12 years’ experience in the pharmaceutical industry as a quality control analyst, stability and validation specialist, head of the stability section and senior quality control chemist. Then he started in medical devices as a laboratory technician. At Ferronova, he is a quality associate responsible for manufacturing, quality control and supplier quality assurance.

Dr Valentina Milanova received her PhD in Biomaterial Engineering and Nanomedicine from the Future Industries institutes (FII), University of South Australia (UniSA) in 2020. In 2015 she was awarded an Australian Postgraduate Awards (APA) to pursue her PhD. Her project was also supported by the Australian Research Council (ARC) Centre of Excellence in Convergent Bio-Nano Science (CBNS). During her PhD, Dr Milanova conducted an ambitious program of research aimed at harnessing the unique properties of nanomaterials towards the development of radiolabelled agents (probes) for cancer nuclear imaging and therapy. Her research delivered several methodological advances and a solid foundation for the design of clinically translatable imaging and therapeutic nanoprobes.

Dr Vien Huynh is a Senior Research Fellow at Key Centre for Polymers and Colloids (KCPC), School of Chemistry at the University of Sydney. He currently works on a Syngenta Crop Protection funded project focussing on polymer coating of active ingredients (agrochemicals). He also works on or involves in other industry-funded projects with various roles ranging from writing proposals, carrying out proof-of-concepts, optimising processes toward transferring technology and scaling up. His research addresses solutions for hard-to-solved problems in agrochemicals, drug delivery, energy, and recycling materials. Dr Huynh studied chemical and food engineering at Ho Chi Minh City University of Technology, Vietnam. He received his Master of Science at The University of Queensland. He was then awarded a highly competitive Endeavour Postgraduate Scholarship to undertake his PhD in polymer chemistry at Centre of Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New South Wales. Since 2012, he has joined the Hawkett group at KCPC as a Research Fellow to undertake the Syngenta funded project. BEng, Ho Chi Minh City University of Technology, Vietnam, 2002 MSc, The University of Queensland, Australia, 2007 PhD, The University of New South Wales, Australia, 2012 Postdoctoral Research Fellow, The University of Sydney, Australia, 2012

Dr Nicole Dmochowska was awarded her PhD in Medicine from the University of Adelaide in 2020. In 2016, she received a prestigious William T Southcott Nuclear Medicine Scholarship and an Australian Government Research Training Program Scholarship to support her PhD. Dr Dmochowska's PhD research focused on developing radiolabelled probes for imaging intestinal inflammation and fibrosis in the context of inflammatory bowel disease. This work contributed to the advancement of our understanding of targeted non-invasive positron emission tomography of the gastrointestinal tract.